From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
IntegriChain provides the most comprehensive systems integration and implementation services for unifying all aspects of market access and revenue management, enabling greater operational efficiency, and improving line-of-sight into patient initiation and adherence.
Despite years of investment, many phama manufacturers still find themselves operating in silos:
Needless to say, this approach leads to significant operational inefficiencies, revenue leakage, sub-par financial performance, and ultimately, barriers to patient initiation and adherence
IntegriChain delivers the most comprehensive and scalable systems integration and implementation services in the industry, having helped hundreds of Life Sciences manufacturers–from emerging innovators to Big Pharma– unify their market access, contracting, and revenue management systems including Model N, Vistex, Agiloft, Apttus, and Chronicled. Our expertise and execution delivers:
IntegriChain delivers scalable services that assist pharmaceutical manufacturers with implementation, upgrade, merger, and support of enterprise software systems. Our offerings cover the entire lifecycle from planning and assessments to implementation and optimization as well as ongoing support and maintenance.
The sooner you can integrate your data across commercial, financial and operational aspects of market access, the sooner you can power your business with the accurate, timely, and consolidated data required to make actionable decisions in an ever-changing industry.
Integrate data from third party platforms and vendors into an accurate, timely, and consolidated single source of truth to power precise analyses and make more informed business decisions.
Learn More
Market Access teams need access to reliable, consistent, and timely patient data in order to quickly identify potential access obstacles, ensure initiation and adherence, and maximize product performance. IntegriChain can turn mountains of questionable patient data into actionable insights for you and your trading partners.
Easily access data and insights across all ICyte channel, patient, contracts, pricing, and gross-to-net data and applications to easily create custom data-on-demand dashboards, reporting, and visualizations.
